|Titre :||Drug treatment expenditure: a methodological overview|
|Editeur :||Lisbonne : EMCDDA, 2017|
|Pagination :||196 p|
GéoAUSTRALIE ; CROATIE ; ETATS UNIS D'AMERIQUE ; EUROPE ; FRANCE ; HONGRIE ; ITALIE ; PORTUGAL ; REPUBLIQUE TCHEQUE ; ROYAUME UNI
SANTEPSYCAS CLINIQUE ; COMORBIDITE ; COMPARAISON ; COUT ; DEPENSE ; DEPENSES DE SANTE ; ECONOMIE ; ETABLISSEMENT DE SANTE ; METHODE ; PRODUIT ILLICITE ; TRAITEMENT ; TRAITEMENT DE SUBSTITUTION ; UNION EUROPEENNE
TABLE OF CONTENTS:
Chapter 1: A methodology for estimating health expenditure on drug treatment: the Australian experience.
Chapter 2: Estimating labelled public expenditure on drug treatment in Croatia.
Chapter 3: Expenditure on drug treatment in the Czech Republic.
Chapter 4: Bottom-up versus top-down methods of cost estimation: the case of medical drug treatment and rehabilitation in Hungary.
Chapter 5: A methodological inventory for the assessment of selected, unlabelled direct public expenditure in the field of drug demand reduction.
Chapter 6: Estimating the costs of treating drug-related health problems in the United Kingdom.
Chapter 7: Public expenditure on drug treatment and associated comorbidities: a case study of Bergamo.
Chapter 8: Public expenditure on opioid substitution treatment in Italy.
Chapter 9: A methodology for an EU cross-country comparison? Public expenditure on drug treatment in hospitals.
Chapter 10: The cost calculator: a tool for estimating public spending on drug treatment in England.
Chapter 11: Empirical estimation of drug treatment costs in Portugal.
Chapter 12: Estimating the costs of substitution therapy for heroin and opioid addiction in the United States: insights and challenges.
Chapter 13: A cross-national comparison of public expenditures on drug treatment: context is key.
Chapter 14: Social cost of illicit drugs in France: what's new in estimating the value for lives lost and illness?
Chapter 15: Estimating drug treatment expenditure: discussion and concluding remarks.
|Hôpital Marmottan||R 1207||Hôpital Marmottan||Rapport||Généralités||Disponible|